These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 31681690)

  • 1. Abdelazim and Sakiyeva endocrinopathy associated with polycystic ovary syndrome: Case reports.
    Abdelazim IA; Kanshaiym S
    J Family Med Prim Care; 2019 Sep; 8(9):3039-3041. PubMed ID: 31681690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Common endocrine disorders associated with the polycystic ovary syndrome.
    Abdelazim IA; Amer OO; Farghali M
    Prz Menopauzalny; 2020 Dec; 19(4):179-183. PubMed ID: 33488329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and Biochemical Characteristics of Polycystic Ovarian Syndrome among Women in Bangladesh.
    Islam S; Pathan F; Ahmed T
    Mymensingh Med J; 2015 Apr; 24(2):310-8. PubMed ID: 26007259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CYP19 gene expression in subcutaneous adipose tissue is associated with blood pressure in women with polycystic ovary syndrome.
    Lecke SB; Morsch DM; Spritzer PM
    Steroids; 2011 Nov; 76(12):1383-8. PubMed ID: 21807013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polycystic ovary syndrome (PCOS), an inflammatory, systemic, lifestyle endocrinopathy.
    Patel S
    J Steroid Biochem Mol Biol; 2018 Sep; 182():27-36. PubMed ID: 29678491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polycystic ovarian syndrome: pathophysiology, molecular aspects and clinical implications.
    Diamanti-Kandarakis E
    Expert Rev Mol Med; 2008 Jan; 10():e3. PubMed ID: 18230193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polycystic ovary syndrome and its differential diagnosis.
    Lane DE
    Obstet Gynecol Surv; 2006 Feb; 61(2):125-35. PubMed ID: 16433936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Genetic aspects of polycystic ovary syndrome].
    Jakubowski L
    Endokrynol Pol; 2005; 56(3):285-93. PubMed ID: 16350721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current and future aspects of several adjunctive treatment strategies in polycystic ovary syndrome.
    Banaszewska B; Pawelczyk L; Spaczynski R
    Reprod Biol; 2019 Dec; 19(4):309-315. PubMed ID: 31606349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The synergistic effect of sex hormone-binding globulin and aromatase genes on polycystic ovary syndrome phenotype.
    Xita N; Georgiou I; Lazaros L; Psofaki V; Kolios G; Tsatsoulis A
    Eur J Endocrinol; 2008 Jun; 158(6):861-5. PubMed ID: 18505907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Impact of Mineral Supplementation on Polycystic Ovarian Syndrome.
    ElObeid T; Awad MO; Ganji V; Moawad J
    Metabolites; 2022 Apr; 12(4):. PubMed ID: 35448525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Novel Letrozole Model Recapitulates Both the Reproductive and Metabolic Phenotypes of Polycystic Ovary Syndrome in Female Mice.
    Kauffman AS; Thackray VG; Ryan GE; Tolson KP; Glidewell-Kenney CA; Semaan SJ; Poling MC; Iwata N; Breen KM; Duleba AJ; Stener-Victorin E; Shimasaki S; Webster NJ; Mellon PL
    Biol Reprod; 2015 Sep; 93(3):69. PubMed ID: 26203175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polycystic Ovary Syndrome.
    Azziz R
    Obstet Gynecol; 2018 Aug; 132(2):321-336. PubMed ID: 29995717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ovarian morphology is a marker of heritable biochemical traits in sisters with polycystic ovaries.
    Franks S; Webber LJ; Goh M; Valentine A; White DM; Conway GS; Wiltshire S; McCarthy MI
    J Clin Endocrinol Metab; 2008 Sep; 93(9):3396-402. PubMed ID: 18559912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transvaginal ultrasound imaging, histopathology and endocrinopathy in patients with polycystic ovarian syndrome.
    Takahashi K; Eda Y; Abu-Musa A; Okada S; Yoshino K; Kitao M
    Hum Reprod; 1994 Jul; 9(7):1231-6. PubMed ID: 7962423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of hyperprolactinemia upon clinical symptoms of patients with polycystic ovary syndrome].
    Wang Y; Hu ZP; Li MZ; Li R; Wang LN; Chen XN; Yang CS; Qiao J
    Zhonghua Yi Xue Za Zhi; 2009 Oct; 89(37):2599-603. PubMed ID: 20137674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of reproductive, metabolic, and endocrine features of polycystic ovary syndrome in female hyperandrogenic mouse models.
    Caldwell AS; Middleton LJ; Jimenez M; Desai R; McMahon AC; Allan CM; Handelsman DJ; Walters KA
    Endocrinology; 2014 Aug; 155(8):3146-59. PubMed ID: 24877633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of
    Mehdizadeh A; Kalantar SM; Sheikhha MH; Aali BS; Ghanei A
    Int J Reprod Biomed; 2017 Aug; 15(8):491-496. PubMed ID: 29082367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of steroidogenesis by vitamin D3 in granulosa cells of the mouse model of polycystic ovarian syndrome.
    Bakhshalizadeh S; Amidi F; Alleyassin A; Soleimani M; Shirazi R; Shabani Nashtaei M
    Syst Biol Reprod Med; 2017 Jun; 63(3):150-161. PubMed ID: 28345956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. No evidence of mutations in the P450 aromatase gene in patients with polycystic ovary syndrome.
    Söderlund D; Canto P; Carranza-Lira S; Méndez JP
    Hum Reprod; 2005 Apr; 20(4):965-9. PubMed ID: 15695318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.